Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Gynecol Oncol. 2019 Jan 25;153(1):116–122. doi: 10.1016/j.ygyno.2019.01.017

Table 1.

Characteristics of HOPE Study Participants, 2003–2008

Controls
(N=1,572)
N (%)
Cases
(N=689)
N (%)
P-Value

Age, years <0.001
 <50 450(28.6) 133(19.3)
 50–54 211(13.4) 96 (13.9)
 55–59 279(17.8) 113(16.4)
 60–64 178(11.3) 93 (13.5)
 65–69 175(11.1) 83 (12.1)
 70+ 279(17.8) 171(24.8)
Race 0.001
 White 1530 (97.3) 652(94.6)
 Black 27(1.7) 31(4.5)
 Other 15(1.0) 6 (0.9)
Education <0.001
 Less than High School 75(4.8) 74 (10.7)
 High School 488(31.0) 249(36.1)
 Post High School Training 495(31.5) 191(27.7)
 College Graduate 514(32.7) 175(25.4)
Menopausal Status 0.003
 Pre-menopausal 481(30.6) 168(24.4)
 Post-menopausal 1039 (66.1) 505(73.3)
 Unknown 52(3.3) 16(2.3)
Body Mass Index (BMI), kg/m2 0.409
 <25 595 (37.9) 243(35.3)
 25–29 466(29.7) 204(29.7)
 ≥30 510(32.5) 241(35.0)
Oral Contraceptive use <0.001
 Never 451(28.7) 271(39.3)
 Ever 1121 (71.3) 418(60.7)
Duration of Oral Contraceptive Use, years <0.001
 0 451(28.7) 271(39.3)
 <1 247(15.7) 126(18.3)
 1–4 425(27.0) 156(22.6)
 5–9 267(17.0) 94 (13.6)
 10+ 182(11.6) 42(6.1)
Number of Full Births 0.212
 1 231(14.7) 120(17.4)
 2 601(38.2) 264(38.3)
 3+ 740(47.1) 305(44.3)
Tubal Ligation <0.001
 No 979(62.3) 496(72.0)
 Yes 593(37.7) 193(28.0)
Hysterectomy 0.002
 No 1284 (81.7) 523(75.9)
 Yes 288(18.3) 166(24.1)
Hormone Replacement Therapy Use 0.984
 Never 982(62.5) 432(62.7)
 Ever 540(34.4) 236(34.3)
 Unknown 50(3.2) 21(3.1)
Smoking Status 0.473
 Never Smoker 779(49.6) 340(49.4)
 Current Smoker 298(19.0) 118(17.1)
 Former Smoker 495(31.4) 231(33.5)
Family History of Breast or Ovarian 0.02
Cancer
 No 1301 (82.9) 541(78.8)
 Yes 269(17.1) 146(21.3)
History of Endometriosis 0.318
 No 1465 (93.2) 634(92.0)
 Yes 107 (6.8) 55(8.0)